Abstract
Cancer remains the second leading cause of death worldwide even though advances in early diagnosis and treatment are being actively pursued. Nanoparticles (NPs) are one of the most widely studied materials in the recent decade and are emerging as promising agents in the cancer management. Pertinent to realizing this truth, toxicity issues related to nanoproducts are of particular concern that is often ignored. Nanostructures synthesised using materials of biological origin using eco-friendly ‘green’ chemistry approach, partially addresses this problem. Biologically synthesised NPs are accounted for various applications in cancer management such as bioimaging, drug delivery, sensitising, photothermal and photodynamic therapy and so on. Cancer stem cells (CSCs) are a small population of extremely tumourigenic and intrinsically drug resistant cells that are responsible for the tumour initiation, progression, resistance, and relapse. In addition to small molecules and nucleic acid-based therapeutics, combining nanomaterials with antibodies against CSC-specific markers or CSC-targeting agents have been engaged for the selective targeting and developing of anti-CSCs therapeutics. Yet despite the benefits reaped by the NPs, in the overall management of complex diseases like cancer, disadvantages such as toxicity and pollution inevitably follow. The first part of this review essentially budges on the application of NPs produced using ‘green’ biological materials, which are poised to dissipate some of the issues. The latter half is aimed to discuss the utility of nanoparticles in CSC-targeted therapies.
Keywords: Cancer stem cells, green chemistry, nanoparticles, nanomedicine, targeted therapy.
Graphical Abstract
Current Nanoscience
Title:Bridging ‘Green’ with Nanoparticles: Biosynthesis Approaches for Cancer Management and Targeting of Cancer Stem Cells
Volume: 12 Issue: 1
Author(s): Manu M. Joseph, Suraj K. George and T. T. Sreelekha
Affiliation:
Keywords: Cancer stem cells, green chemistry, nanoparticles, nanomedicine, targeted therapy.
Abstract: Cancer remains the second leading cause of death worldwide even though advances in early diagnosis and treatment are being actively pursued. Nanoparticles (NPs) are one of the most widely studied materials in the recent decade and are emerging as promising agents in the cancer management. Pertinent to realizing this truth, toxicity issues related to nanoproducts are of particular concern that is often ignored. Nanostructures synthesised using materials of biological origin using eco-friendly ‘green’ chemistry approach, partially addresses this problem. Biologically synthesised NPs are accounted for various applications in cancer management such as bioimaging, drug delivery, sensitising, photothermal and photodynamic therapy and so on. Cancer stem cells (CSCs) are a small population of extremely tumourigenic and intrinsically drug resistant cells that are responsible for the tumour initiation, progression, resistance, and relapse. In addition to small molecules and nucleic acid-based therapeutics, combining nanomaterials with antibodies against CSC-specific markers or CSC-targeting agents have been engaged for the selective targeting and developing of anti-CSCs therapeutics. Yet despite the benefits reaped by the NPs, in the overall management of complex diseases like cancer, disadvantages such as toxicity and pollution inevitably follow. The first part of this review essentially budges on the application of NPs produced using ‘green’ biological materials, which are poised to dissipate some of the issues. The latter half is aimed to discuss the utility of nanoparticles in CSC-targeted therapies.
Export Options
About this article
Cite this article as:
Joseph M. Manu, George K. Suraj and Sreelekha T. T., Bridging ‘Green’ with Nanoparticles: Biosynthesis Approaches for Cancer Management and Targeting of Cancer Stem Cells, Current Nanoscience 2016; 12 (1) . https://dx.doi.org/10.2174/1573413711666150624170401
DOI https://dx.doi.org/10.2174/1573413711666150624170401 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Status of Flavonols as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Current Cancer Therapy Reviews Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer
Current Pharmaceutical Design Four-Component Synthesis of 1,2-Dihydropyridine Derivatives and their Evaluation as Anticancer Agents
Medicinal Chemistry Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology
Current Pharmaceutical Design Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches
Current Medicinal Chemistry Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design 2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA
Current Computer-Aided Drug Design Nanomedicine: Enhancement of Chemotherapeutical Efficacy of Docetaxel by Using a Biodegradable Nanoparticle Formulation
Current Pharmaceutical Design Editorial [ Infectious Diseases: What is in our future? ]
Infectious Disorders - Drug Targets Photosensitizer Nanoparticles for Photodynamic Therapy
Current Bioactive Compounds HER-2 Signaling and Inhibition in Breast Cancer
Current Cancer Drug Targets Biologics as Treatment for Systemic Lupus: Great Efforts, Sobering Results, New Challenges
Current Drug Discovery Technologies Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks
Current Medicinal Chemistry Thiourea and Guanidine Derivatives as Antimalarial and Antimicrobial Agents<sup>§</sup>
Current Topics in Medicinal Chemistry Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity
Current Medicinal Chemistry A Review of Aberrant DNA Methylation and Epigenetic Agents Targeting DNA Methyltransferases in Endometriosis
Current Drug Targets Knee Meniscus Segmentation and Tear Detection from MRI: A Review
Current Medical Imaging Controlled Exploration of Structural Databases: The Case of Farnesyl Transferase Inhibitors
Medicinal Chemistry How Much is Enough? Modulation of Dose-Response Curve for Steroid Receptor-Regulated Gene Expression by Changing Concentrations of Transcription Factor
Current Topics in Medicinal Chemistry Recent Progress in Structure Activity Relationship and Mechanistic Studies of Taxol Analogues
Mini-Reviews in Medicinal Chemistry